Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ruben Nogueiras, Petra Wiedmer, Diego Perez-Tilve, Christelle Veyrat-Durebex, Julia M. Keogh, Gregory M. Sutton, Paul T. Pfluger, Tamara R. Castaneda, Susanne Neschen, Susanna M. Hofmann, Philip N. Howles, Donald A. Morgan, Stephen C. Benoit, Ildiko Szanto, Brigitte Schrott, Annette Schürmann, Hans-Georg Joost, Craig Hammond, David Y. Hui, Stephen C. Woods, Kamal Rahmouni, Andrew A. Butler, I. Sadaf Farooqi, Stephen O’Rahilly, Françoise Rohner-Jeanrenaud, Matthias H. Tschöp
Published in Volume 117, Issue 11
J Clin Invest. 2007; 117(11):3475–3488 doi:10.1172/JCI31743
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 8
Schematic overview summarizing the physiological effects of CNS-Mcr blockade on peripheral tissues.

Blockade of CNS-Mcr decreases thermogenesis and glucose utilization in BAT; decreases glucose utilization in muscle; increases TAG content, lipoprotein assembly, and secretion in liver; and increases TAG synthesis and uptake as well as glucose uptake and insulin sensitivity in fat tissue. Combined, these parallel metabolic changes in multiple tissues represent a synergistic shift in substrate choice and nutrient partitioning, resulting in increased energy storage.